Latest total revenue for HEXO: $120M, below the Healthcare sector average of $110B.
Get informed when a big investor buys or sells
+ FollowAs of Apr 2023
Trailing 12 months ending Apr 2023
HEXO (HEXO) currently reports a total revenue of $120M as of April 2023. That compares with $190M in the prior-year period — down 33.7% year over year. That is below the Healthcare sector average of $110B. Use the charts on this page to explore HEXO's total revenue history and peer comparisons.
HEXO's total revenue decreased from $190M to $120M — a 33.7% year-over-year decrease (period ending April 2023). Watching multi-year history on the chart below helps separate one-off swings from a lasting trend.
HEXO's total revenue of $120M is lower than the Healthcare sector average of $110B. That is roughly 99.9% below the sector mean. A reading lower peers can reflect different growth expectations, capital structure, or profitability — so it is worth checking the peer comparison chart before drawing conclusions.
HEXO reported $120M in total revenue as of April 2023. That compares with $190M in the prior-year period — down 33.7% year over year. Absolute dollar amounts are most useful when compared with prior periods, peers, and related line items such as revenue, assets, or liabilities on Stockcircle.
Start with the current total revenue of $120M, then check the historical chart for trend and the peer comparison chart for relative positioning. The Healthcare average is $110B. From there, open related valuation or income-statement pages for HEXO, and consider following HEXO for alerts when major investors trade the stock.